Cell Signaling Technology (United States)
Cell Signaling Technology, Inc. is a privately held company that develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Cell Signaling Technology (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
522
Total Open
Publications
372
Total
Citations
67K
Open Access
Percentage
71%
Total
Publications
522
Total Open
Publications
372
Total
Citations
67K
Breakdown
Publisher Open
12%
Both
40%
Other Platform Open
19%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
63
Hybrid 48%
132
No Guarantees 29%
79
Other Platform Open
Domain 88%
268
Institution 13%
40
Preprint 12%
37
Public 11%
33
Other Internet 8%
26
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 267 |
Europe PMC | Domain | 189 |
Figshare | Public | 46 |
bioRxiv | Preprint | 31 |
DOI | Other Internet | 19 |
Semantic Scholar | Public | 16 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 9 |
Massachusetts Institute of Technology - DSpace@MIT | Institution | 6 |
University of California - eScholarship University of California | Institution | 5 |
California Digital Library - eScholarship | Other Internet | 5 |